INOPERABLE DISEASE

Clinical trials for INOPERABLE DISEASE explained in plain language.

Never miss a new study

Get alerted when new INOPERABLE DISEASE trials appear

Sign up with your email to follow new studies for INOPERABLE DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 3

New triple-drug attack aims to revive immune response in hard-to-treat melanoma

Disease control Recruiting now

This phase 2 trial tests whether combining high-dose interleukin-2 with low-dose ipilimumab, followed by nivolumab, can shrink tumors in people with advanced melanoma that has stopped responding to prior immunotherapy. About 29 participants with inoperable stage III or IV melanom…

Matched conditions: INOPERABLE DISEASE

Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control

Last updated Jun 27, 2026 12:02 UTC

INOPERABLE DISEASE

Get alerted when new INOPERABLE DISEASE trials appear

New triple-drug attack aims to revive immune response in hard-to-treat melanoma